OPACT® DMCC 25 is a co-processed excipient composed of mannitol, microcrystalline cellulose, and silicon dioxide. Designed for pharmaceutical and health food applications, it is specifically engineered to support the formulation and production of orally disintegrating tablets.
Item No :
OPACT® DMCC 25Product Origin :
CHINAShipping Port :
SHANG HAIPayment :
TT/LCWeight :
20/25KGOrder(MOQ) :
100KG
OPACT® DMCC 25 is a high-performance co-processed excipient that combines mannitol, microcrystalline cellulose, and silicon dioxide through advanced co-processing technology. This structural integration creates a synergistic effect, delivering enhanced performance that surpasses traditional physical mixtures. Engineered to be multi-functional, it addresses various critical formulation needs in modern pharmaceutical manufacturing. By leveraging specialized excipient technology, OPACT® DMCC 25 effectively resolves complex formulation challenges, providing a reliable and efficient solution for producing high-quality solid dosage forms.
OPACT® DMCC 25 is primarily utilized in the formulation, research, and large-scale production of orally disintegrating tablets (ODTs) for both pharmaceutical and health food products. Its co-processed composition makes it particularly suitable for direct compression and dry granulation processes, enabling manufacturers to develop patient-friendly dosage forms that rapidly disintegrate in the mouth without water. This excipient ensures that the final tablets meet stringent quality standards while significantly improving patient compliance and convenience, making it an indispensable component in modern oral solid dosage form development.
| Loss on Drying (%) | Bulk Density (g/ml) |
Packaging Size (kg) |
|---|---|---|
|
≤ 4.0 |
0.30-0.40 |
20 |